Food News and Research

RSS

Valeant to acquire rights relating to Elidel and Xerese from Meda

Valeant Pharmaceuticals International, Inc. announced today that its subsidiary, Valeant International SRL (VIB), has signed an agreement to acquire rights to both Elidel and Xerese from Meda, an international specialty pharmaceutical company for the U.S., Canada and Mexico.

30 Jun 2011

New technique can remove oil spill from soil

It is well known just how damaging oil can be to nature. It is also well known just how difficult it can be to clean up after a spill or contamination. Removing an oil spill or contamination from soil is hard and requires very different techniques to removing oil from water.

30 Jun 2011

Tips to stay healthy during vacation

Do you ever wonder why you feel so exhausted after returning from a vacation? The flights, car rides, hotel stays and on-the-go activities just might play a part in the way you feel. Dr. Marbella Zumaya, a physician with Covenant Medical Group, gives some tips on how to stay healthy while vacationing as well as how to come back feeling refreshed.

30 Jun 2011

Almirall, Forest Labs submit aclidinium bromide NDA to FDA for treatment of COPD

Forest Laboratories, Inc. and Almirall, S.A. announced they have recently submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for aclidinium bromide, a long-acting inhaled antimuscarinic agent developed for the treatment of COPD.

30 Jun 2011

Recombinant attenuated Salmonella vaccines hold promise against infectious diseases

A powerful new class of therapeutics, known as recombinant attenuated Salmonella vaccines (RASV), holds great potential in the fight against fatal diseases including hepatitis B, tuberculosis, cholera, typhoid fever, AIDS and pneumonia.

30 Jun 2011

Physicians urge FDA not to approve Truvada as an HIV prevention pill

Last week, a group of 55 U.S. physicians sent a letter to the U.S. Food & Drug Administration (FDA), urging the agency not to approve the use of Gilead's HIV/AIDS treatment drug Truvada for use as an HIV prevention pill - also known as "pre-exposure prophylaxis" (PrEP).

30 Jun 2011

Conference examines lagging ethical guidelines in face of expanding clinical trials in developing countries

SciDev.Net reports on the 7th World Conference of Science Journalists, taking place this week in Qatar, where participants discussed how the number of clinical trials in developing countries is surging despite legal and ethical frameworks often not being in place.

30 Jun 2011

TCGA examines ovarian serous adenocarcinoma tumors from 500 patients

An analysis of genomic changes in ovarian cancer has provided the most comprehensive and integrated view of cancer genes for any cancer type to date. Ovarian serous adenocarcinoma tumors from 500 patients were examined by The Cancer Genome Atlas (TCGA) Research Network and analyses are reported in the June 30, 2011, issue of Nature.

30 Jun 2011

FDA's ODAC recommends withdrawal of Avastin approval for metastatic breast cancer

Genentech, a member of the Roche Group, announced today that, during a U.S. Food and Drug Administration (FDA) hearing, the FDA's Oncologic Drugs Advisory Committee (ODAC) recommended that the FDA withdraw its approval of Avastin in combination with paclitaxel chemotherapy for previously untreated HER2-negative metastatic breast cancer.

30 Jun 2011

Provectus presents additional data on PV-10 at two separate melanoma conferences

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that data and study design features on PV-10 for metastatic melanoma were presented at two separate conferences.

30 Jun 2011

Dendreon receives FDA approval for Los Angeles cancer immunotherapy manufacturing facility

Dendreon Corporation today announced that the U.S. Food and Drug Administration approved its Los Angeles cancer immunotherapy manufacturing facility, allowing the company to continue to increase the availability of PROVENGE across the U.S. to help meet the needs of patients with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer.

30 Jun 2011

Viewpoints: Calif.'s budget, Supreme Court drug rulings, the Avastin debate

The budget is not realistic, counting on fantastical revenue projections as well as a redevelopment gambit that's likely to be blocked in court. It makes deep cuts in state programs that will have unwelcome repercussions in years to come. And if the revenue projections prove to be as overly optimistic as they seem, there will be more damaging cuts to education, child care and health services. Nevertheless, it's a more earnest effort to clean up the state's budget mess than Sacramento has seen in a decade or more.

30 Jun 2011

Vaccines may be given in food in the near future

Soon children could be vaccinated with bacteria mixed in milk and people in the developing world given unprecedented access to immunisations under a scheme proposed by an Australian Nobel laureate, Barry Marshall.

29 Jun 2011

FDA looks at Avastin risks

The US Food and Drug Administration is holding a two-day hearing that pits the FDA's Center for Drug Evaluation and Research against Genentech, that manufactures breast cancer drug Avastin. A handful of breast cancer patients testified Tuesday that Avastin helped in treating their metastatic breast cancer but a review of studies conducted by the FDA's Center for Drug Evaluation and Research suggests the risks outweigh the benefits of Avastin for treating breast cancer, FDA officials said at the hearing.

29 Jun 2011

Patients, scientists in different corners for cancer drug fight

The drug, Avastin, will be the subject of an unusual Food and Drug Administration hearing to revisit a panel vote last July that steered many doctors away from prescribing the drug for the treatment of breast cancer.

29 Jun 2011

China Health first quarter gross revenues increase 52% to $6.759 million

China Health Labs & Diagnostics Ltd. is pleased to announce the financial results for the first quarter ended March 31, 2011.

29 Jun 2011

Cipher grants Vertical exclusive U.S. distribution rights to CIP-TRAMADOL ER

Cipher Pharmaceuticals Inc. today announced that it has entered into a definitive distribution and supply agreement with Vertical Pharmaceuticals, Inc., a U.S.-based specialty pharmaceutical company, under which Cipher has granted Vertical the exclusive right to market, sell and distribute CIP-TRAMADOL ER in the United States.

29 Jun 2011

A.P. Pharma enters into definitive agreements for $24M private placement of common stock and warrants

A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that it has entered into definitive agreements with certain new and existing accredited investors providing for a private placement of common stock and warrants in which the Company will receive $24 million in gross proceeds.

29 Jun 2011

NEC's MultiSync MD301C4 medical diagnostic display receives FDA 510(k) marketing clearance

NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food & Drug Administration 510(k) market clearance of the 30-inch MultiSync MD301C4 medical diagnostic display for the displaying and viewing of digital images for diagnosis by trained physicians.

29 Jun 2011

New FAO Director General says he wants to help food importing developing countries address high food prices

In a news conference on Monday, Jose Graziano da Silva, the newly elected head of the U.N. Food and Agriculture Organization (FAO), said he wants to do more to help poor countries deal with volatile food prices, Reuters reports.

29 Jun 2011

Food News and Research

Valeant to acquire rights relating to Elidel and Xerese from Meda

New technique can remove oil spill from soil

Tips to stay healthy during vacation

Almirall, Forest Labs submit aclidinium bromide NDA to FDA for treatment of COPD

Recombinant attenuated Salmonella vaccines hold promise against infectious diseases

Physicians urge FDA not to approve Truvada as an HIV prevention pill

Conference examines lagging ethical guidelines in face of expanding clinical trials in developing countries

TCGA examines ovarian serous adenocarcinoma tumors from 500 patients

FDA's ODAC recommends withdrawal of Avastin approval for metastatic breast cancer

Provectus presents additional data on PV-10 at two separate melanoma conferences

Dendreon receives FDA approval for Los Angeles cancer immunotherapy manufacturing facility

Viewpoints: Calif.'s budget, Supreme Court drug rulings, the Avastin debate

Vaccines may be given in food in the near future

FDA looks at Avastin risks

Patients, scientists in different corners for cancer drug fight

China Health first quarter gross revenues increase 52% to $6.759 million

Cipher grants Vertical exclusive U.S. distribution rights to CIP-TRAMADOL ER

A.P. Pharma enters into definitive agreements for $24M private placement of common stock and warrants

NEC's MultiSync MD301C4 medical diagnostic display receives FDA 510(k) marketing clearance

New FAO Director General says he wants to help food importing developing countries address high food prices

Understanding cultivated meat and its global potential eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News